UBS Reiterates Buy on salesforce.com (CRM) Following 2Q Report

BMO Capital Cuts Price Target on salesforce.com (CRM) to $86 Following 2Q Report

September 1, 2016 10:02 AM EDT

BMO Capital maintained an Outperform rating on salesforce.com (NYSE: CRM), and cut the price target to $86.00 (from $98.00), following the company's 2Q earnings report. Revenue and EPS were ahead of consensus estimates. However, billings came in weaker than expected.

Analyst Keith Bachman... More

Oppenheimer Reiterates Outperform on salesforce.com (CRM) Following 2Q Report

September 1, 2016 9:51 AM EDT

Oppenheimer reiterated an Outperform rating and $95.00 price target on salesforce.com (NYSE: CRM) following the company's 2Q earnings report. CRM reported total revenue of $2.036B was ~$16M above the consensus. EPS of $0.24 was $0.02 above consensus. Total revenue guidance is $2.11-2.12B and compares to the $2.12B consensus. PF EPS guidance is $0.20-0.21, which is... More

Pre-Open Stock Movers 09/01: (CYNA) (OXM) (OLLI) Higher; (GCO) (CRM) (SCVL) Lower (more...)

September 1, 2016 9:23 AM EDT

Pre-Open Stock Movers

Cynapsus Therapeutics Inc. (NASDAQ: CYNA) 115% HIGHER; Sunovion Pharmaceuticals Inc. and Cynapsus Therapeutics Inc. (NASDAQ: CYNA) announced that the companies have signed a definitive agreement under which Sunovion will acquire Cynapsus for US$40.50 per share in cash. The transaction has received unanimous approval by the Board of Directors of both companies and values Cynapsus at approximately US$624 million (or approximately CAN$820 million). The acquisition will be funded with cash... More

salesforce.com (CRM): Time To Buy, Not Cry - Piper Jaffray

September 1, 2016 8:35 AM EDT

Piper Jaffray analyst, Alex Zukin, reiterated his Overweight rating on shares of salesforce.com (NYSE: CRM) after Salesforce's 2Q17 results failed to live up to investor expectations with the company noting weakness in the U.S. as a driving factor.

The analyst... More

salesforce.com's (CRM) Q2 Miss Seen as "Perplexing' - Deutsche Bank

September 1, 2016 8:27 AM EDT

Deutsche Bank maintained a Buy rating on salesforce.com (NYSE: CRM) but trimmed its price target to $90.00 (from $95.00). The change follows weak Q2 results. Analyst Karl Keirstead said soft results were puzzling.

"The miss is perplexing, as we haven't picked up strong... More

Cowen Remains Bullish on salesforce.com (CRM) Following 2Q

September 1, 2016 8:10 AM EDT

Cowen reiterated an Outperform rating and $100.00 price target on salesforce.com (NYSE: CRM) following the company's 2Q earnings report.

Analyst Derrick Wood commented, "CRM called out end-of-qtr softness in the U.S. that seemingly weighed on hitting internal bookings targets. But... More

Wedbush Reiterates Outperform on salesforce.com (CRM) Following 2Q Report

September 1, 2016 8:00 AM EDT

Wedbush maintained an Outperform rating on salesforce.com (NYSE: CRM), and cut the price target to $96.00 (from $98.00), following the company's 2Q earnings report. Revenue of $2.0B was $17M above consensus, and the company beat EPS estimates by $0.02. Industry and partner checks dont point... More

Jefferies Maintains Cautious Stance on Salesforce (CRM) Following Weak Qtr

September 1, 2016 7:38 AM EDT

Jefferies analyst John DiFucci reiterated a Hold rating and $80 price target on salesforce.com (NYSE: CRM) following a weak quarter with little clarity.

DiFucci commented, "CRM beat headline expectations but missed billings, and New Sub ACV declined modestly yoy. F3Q guidance... More

Wall Street flat as tech offsets manufacturing data

September 1, 2016 7:21 AM EDT

By Chuck Mikolajczak

NEW YORK (Reuters) - U.S. stocks were flat on Thursday, with gains in the tech sector offseting sluggish factory activity data and lower oil prices, as investors exercised caution ahead of a key payrolls report on Friday.

A report from the Institute of Supply Management showed U.S. factory activity contracted for the first time in six months in August as new orders and production tumbled, but data on the labor market pointed to a pickup in third-quarter economic growth.

"The ISM data was, in a word, disappointing, because many investors and market... More

BTIG Affirms salesforce.com (CRM) at 'Buy'; Q2 Results May Draw Questions, but L-T Targets Remain in Focus

September 1, 2016 7:10 AM EDT

BTIG affirms salesforce.com (NYSE: CRM) at Buy with a price target of $100 following the company's Q2 results on Wednesday night.

Analyst Joel Fishbein noted, While Salesforce delivered an in-line 2Q print on most metrics, investors will debate the full implications of the underwhelming billings performance and guidance. Specifically, billings grew only +15% y/y, with softness... More

salesforce.com (CRM): Billings Deceleration Forces A PT Cut - Mizuho

September 1, 2016 7:10 AM EDT

Mizuho Securities analyst, Abhey Lamba, reiterated his Buy rating on shares of salesforce.com (NYSE: CRM) but cut his price target to $85.00 (from $100.00) after Salesforce.com reported mixed F2Q results.

The company beat on revenue and EPS, while billings showed meaningful... More

Option volume flows

September 1, 2016 5:29 AM EDT

Stocks and options expected to have increasing volume: CRM BOX CTRP FIVE LULU F GM CPB CIEN

Options with increasing call volume on August 31; JNK HDP VIAV BOX ASNA VEEV LGF HIMX ISIL

Options with increasing put volume on August 31; EXPR WPX CERS PSTG BOX AG HRB XAU CHS VEEV AMAG CIEN

... More

After-Hours Stock Movers 08/31: (CYNA) (OXM) (OLLI) Higher; (CRM) (SCVL) (FIVE) Lower (more...)

August 31, 2016 5:46 PM EDT

After-Hours Movers

Cynapsus Therapeutics Inc. (NASDAQ: CYNA) 119% HIGHER; Sunovion Pharmaceuticals Inc. and Cynapsus Therapeutics Inc. (NASDAQ: CYNA) announced that the companies have signed a definitive agreement under which Sunovion will acquire Cynapsus for US$40.50 per share in cash. The transaction has received unanimous approval by the Board of Directors of both companies and values Cynapsus at approximately US$624 million (or approximately CAN$820 million). The acquisition will be funded with cash on hand. The transaction is expected to close in the fourth quarter of 2016... More

Salesforce third-quarter revenue forecast misses, shares fall

August 31, 2016 4:15 PM EDT

By Aishwarya Venugopal and Gayathree Ganesan

(Reuters) - Cloud software maker Salesforce.com Inc (NYSE: CRM) forecast third-quarter revenue below estimates as it saw some softness, primarily in the United States, sending the company's shares down by 7.7 percent in extended trading.

For the third quarter, Salesforce said it expected an adjusted profit of 20-21 cents per share and revenue of $2.11 billion-$2.12 billion.

Analysts on average were expecting an adjusted profit... More

salesforce.com (CRM) Tops Q2 EPS by 2c; Issues Light Q3 Outlook

August 31, 2016 4:06 PM EDT

salesforce.com (NYSE: CRM) reported Q2 EPS of $0.24, $0.02 better than the analyst estimate of $0.22. Revenue for the quarter came in at $2.04 billion versus the consensus estimate of $2.02 billion.

GUIDANCE:

salesforce.com sees Q3 2017 EPS of $0.20-$0.21, versus the consensus of... More

Salesforce.com (CRM) September implied volatility elevated into Q2 and outlook

August 31, 2016 1:57 PM EDT

salesforce.com (NYSE: CRM) September weekly call option implied volatility is at 93, September is at 41, October is at 32; compared to its 52-week range of 34 to 79 into the expected release of Q2 results today after the market close.

... More

Trading Radar for 08/31: salesforce.com (CRM), Box (BOX), Ctrip (CTRP), Brown-Forman (BF-A) Report

August 30, 2016 2:56 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
8:15am EDT

ADP Employment Change - Street sees 170k

Earnings:

Bob Evans Farms (Nasdaq: BOBE) - consensus EPS... More